| Attributes | Values |
|---|
| rdf:type
| |
| description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в червні 1997 (uk)
- im Juni 1997 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en xunu de 1997 (ast)
- գիտական հոդված հրատարակված 1997 թվականի հունիսի 1-ին (hy)
- scientific article published on 01 June 1997 (en)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| author name string
| |
| author name string
| - Boerwinkle E
- Bruschke AV
- Lie KI
- Hayden MR
- Kastelein JJ
- Groenemeijer BE
- Kuivenhoven JA
- Jansen H
- Reymer PW
- Gagné E
- Bruin T
- Hallman MD
|
| rdfs:label
| - Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the li (en)
- Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the li (nl)
|
| skos:prefLabel
| - Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the li (en)
- Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the li (nl)
|
| name
| - Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the li (en)
- Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the li (nl)
|
| title
| |
| title
| - Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1161/01.CIR.95.12.2628
|
| is about
of | |
| is cites work
of | - Coronary artery disease and dyslipidemia within Europe: genetic variants in lipid transport gene loci in German subjects with premature coronary artery disease
- Detection of missense mutations in the genes for lipoprotein lipase and hepatic triglyceride lipase in patients with dyslipidemia undergoing coronary angiography
- Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors
- Influence of common variants in the CETP, LPL, HL and APO E genes on LDL heterogeneity in healthy, middle-aged men.
- Prediction of genetic risk for dyslipidemia
- A multilocus genotyping assay for candidate markers of cardiovascular disease risk
- High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions
- A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study
- Relationship of abdominal adiposity and dyslipemic status in women with a common mutation in the lipoprotein lipase gene
- Linkage and association studies of the lipoprotein lipase gene with postheparin plasma lipase activities, body fat, and plasma lipid and lipoprotein concentrations : The HERITAGE family study
- Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study
- Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart Study
- Molecular genetics of myocardial infarction
- Identification of possible genetic polymorphisms involved in cancer cachexia: a systematic review
- Sex-associated effect of CETP and LPL polymorphisms on postprandial lipids in familial hypercholesterolaemia
- Genetic variation at the lipoprotein lipase locus and plasma lipoprotein and insulin levels in the Québec Family Study
- LPL polymorphism predicts stroke risk in men
- Lipoprotein lipase mutations and Alzheimer's disease.
- S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in 3 prospective cohort studies
- Associations of three lipoprotein lipase gene polymorphisms, lipid profiles and coronary artery disease
- Fh-Souassi: a founder frameshift mutation in exon 10 of the LDL-receptor gene, associated with a mild phenotype in Tunisian families
- Lipoprotein lipase gene is in linkage with blood pressure phenotypes in Chinese pedigrees
- The LPL S447X cSNP is associated with decreased blood pressure and plasma triglycerides, and reduced risk of coronary artery disease
- Interaction Effects of Lipoprotein Lipase Polymorphisms with Lifestyle on Lipid Levels in a Korean Population: A Cross-sectional Study
- Postprandial lipemia and coronary risk
- Genetic basis of interindividual susceptibility to cancer cachexia: selection of potential candidate gene polymorphisms for association studies
- Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism
- Current clinical evidence on pioglitazone pharmacogenomics.
- Human genetics of variation in high-density lipoprotein cholesterol
- Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa heart study
- Lipoprotein lipase gene S447X polymorphism modulates the relation between central obesity and serum lipids, a twin study.
- Association of lipoprotein lipase gene polymorphisms with coronary artery disease among Filipinos
- Gene therapy for dyslipidemia: a review of gene replacement and gene inhibition strategies
- Association of lipoprotein lipase and apolipoprotein C-III genes polymorphism with acute myocardial infarction in diabetic patients
- Postprandial triglyceride levels in familial combined hyperlipidemia. The role of apolipoprotein E and lipoprotein lipase polymorphisms
- The common biological basis for common complex diseases: evidence from lipoprotein lipase gene
- No association between the lipoprotein lipase S447X polymorphism and Alzheimer's disease.
- Roles for lipoprotein lipase in Alzheimer's disease: an association study
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)